Institute for Systems Biology focuses on some of the most pressing issues in human health, including cancer and brain health. ISB President and Professor James Heath, PhD, is a PICI investigator who bridges cutting-edge technology and immune system biology. He builds new technologies to investigate how individual patients’ immune systems respond to therapeutic interventions including vaccines, checkpoint blockade and CAR-T cell therapy. He collaborates with PICI in high-need areas, pushing progress in glioblastoma and brain tumor research. James Heath, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Research Project Brain Tumor Program Point of View How to Engage Your Employees During a Pandemic Our Impact, Patient Story A Legacy of Service and a New Day for Pancreatic Cancer Cancer Research Heroes, Our Impact The Power and Promise of High-Risk Science Announcement, Our Impact, Press Release, Research Update Neoantigen Alliance IDs Parameters for Cancer Vaccines Announcement, Press Release PICI Appoints John Connolly as Chief Scientific Officer Research Project CANDEL: A first-of-its-kind data analysis engine for scientific discovery
Announcement, Our Impact, Press Release, Research Update Neoantigen Alliance IDs Parameters for Cancer Vaccines